Catheter ablation for atrial fibrillation: current patient selection and outcomes

References

• Haim M, Hoshen M, Reges O, et al. Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc. 2015 Jan 21;4(1):e001486. PubMed PMID: 25609415; PubMed Central PMCID: PMCPMC4330072. eng.
   PubMed Web of Science ®Google Scholar
• Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–1147.
   PubMed Web of Science ®Google Scholar
• Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England J Med. 1998;339(10):659–666. PubMed PMID: 9725923.
   PubMed Web of Science ®Google Scholar
• Santangeli P, Zado ES, Hutchinson MD, et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm. 2016 Feb;13(2):374–382. PubMed PMID: 26477712.
   PubMed Web of Science ®Google Scholar
• Santangeli P, Marchlinski FE. Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm. 2017;14(7):1087–1096.
   PubMed Web of Science ®Google Scholar
• Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 Oct;14(10):e275–e444. PubMed PMID: 28506916.
   PubMed Web of Science ®Google Scholar
• Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016 Jun 9;374(23):2235–2245. PubMed PMID: 27042964.
   PubMed Web of Science ®Google Scholar
• Ucer E, Janeczko Y, Seegers J, et al. A randomized trial to compare the acute reconnection after pulmonary vein isolation with laser-balloon versus radiofrequency ablation: RATISBONA trial. J Cardiovasc Electrophysiol. 2018 May;29(5):733–739. PubMed PMID: 29436052; eng.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Koruth J, Jais P, et al. Ablation of atrial fibrillation with pulsed electric fields. JACC: Clin Electrophysiol. 2018. DOI:10.1016/j.jacep.2018.04.005
   Google Scholar
• Wojtaszczyk A, Caluori G, Pesl M, et al. Irreversible electroporation ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2018 Apr;29(4):643–651. PubMed PMID: 29399927; eng.
   PubMed Web of Science ®Google Scholar
• Piccini JP, Lopes RD, Kong MH, et al. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol. 2009 Dec;2(6):626–633. PubMed PMID: 20009077; eng.
   PubMed Web of Science ®Google Scholar
• Forleo GB, De Martino G, Mantica M, et al. Clinical impact of catheter ablation in patients with asymptomatic atrial fibrillation: the IRON-AF (Italian registry on NavX atrial fibrillation ablation procedures) study. Int J Cardiol. 2013 Oct 9;168(4):3968–3970. PubMed PMID: 23886532; eng.
   PubMed Web of Science ®Google Scholar
• Mohanty S, Santangeli P, Mohanty P, et al. Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol. 2014 Oct;25(10):1057–1064. PubMed PMID: 24903064; eng.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016 Oct 7;37(38):2893–2962. PubMed PMID: 27567408.
   PubMed Web of Science ®Google Scholar
• Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011 Sep 27;58(14):1474–1481. PubMed PMID: 21939832.
   PubMed Web of Science ®Google Scholar
• Everett T, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm. 2007 Mar;4(3 Suppl):S24–S27. PubMed PMID: 17336879; PubMed Central PMCID: PMCPMC1850572. eng.
   PubMed Web of Science ®Google Scholar
• Verma A, Kalman JM, Callans DJ. Treatment of patients with atrial fibrillation and heart failure with reduced ejection fraction. Circulation. 2017 Apr 18;135(16):1547–1563. PubMed PMID: 28416525; eng.
   PubMed Web of Science ®Google Scholar
• Van Gelder IC, Crijns HJ, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 1993 Sep 1;72(7):560–566. PubMed PMID: 8362771; eng.
   PubMed Web of Science ®Google Scholar
• Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997 Mar 15;29(4):709–715. PubMed PMID: 9091514; eng.
   PubMed Web of Science ®Google Scholar
• Dandamudi G, Rampurwala AY, Mahenthiran J, et al. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm. 2008 Aug;5(8):1111–1114. PubMed PMID: 18675220; eng.
   PubMed Web of Science ®Google Scholar
• Gentlesk PJ, Sauer WH, Gerstenfeld EP, et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Jan;18(1):9–14. PubMed PMID: 17081210.
   PubMed Web of Science ®Google Scholar
• Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. New England J Med. 2008;358(25):2667–2677. PubMed PMID: 18565859.
   PubMed Web of Science ®Google Scholar
• Torp-Pedersen C, Møller M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. New England J Med. 1999;341(12):857–865. PubMed PMID: 10486417.
   PubMed Web of Science ®Google Scholar
• Khan MN, Jaïs P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. New England J Med. 2008;359(17):1778–1785. PubMed PMID: 18946063.
   PubMed Web of Science ®Google Scholar
• Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (The CAMTAF Trial). Circ Arrhythm Electrophysiol. 2014;7(1):31.
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018 Feb 1;378(5):417–427. PubMed PMID: 29385358.
   PubMed Web of Science ®Google Scholar
• Inada K, Yamane T, Tokutake K, et al. The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up. Europace. 2014 Feb;16(2):208–213. PubMed PMID: 23751930.
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Munger TM, Friedman PA, et al. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2008 Oct;19(10):1009–1014. PubMed PMID: 18479329; eng.
   PubMed Web of Science ®Google Scholar
• Di Donna P, Olivotto I, Delcre SD, et al. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. Europace. 2010 Mar;12(3):347–355. PubMed PMID: 20173211; eng.
   PubMed Web of Science ®Google Scholar
• Gaita F, Di Donna P, Olivotto I, et al. Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2007 Jun 1;99(11):1575–1581. PubMed PMID: 17531584; eng.
   PubMed Web of Science ®Google Scholar
• Koopman P, Nuyens D, Garweg C, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011 Oct;13(10):1386–1393. PubMed PMID: 21646230; eng.
   PubMed Web of Science ®Google Scholar
• Furlanello F, Lupo P, Pittalis M, et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol. 2008 May;19(5):457–462. PubMed PMID: 18266680; eng.
   PubMed Web of Science ®Google Scholar
• Calvo N, Mont L, Tamborero D, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010 Jan;12(1):30–36. PubMed PMID: 19923171; PubMed Central PMCID: PMCPMC2793023. eng.
   PubMed Web of Science ®Google Scholar
• Pathak RK, Middeldorp ME, Lau DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014 Dec 2;64(21):2222–2231. PubMed PMID: 25456757.
   PubMed Web of Science ®Google Scholar
• Pathak RK, Middeldorp ME, Meredith M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015 May 26;65(20):2159–2169. PubMed PMID: 25792361.
   PubMed Web of Science ®Google Scholar
• Pathak RK, Elliott A, Middeldorp ME, et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT Study. J Am Coll Cardiol. 2015 Sep 1;66(9):985–996. PubMed PMID: 26113406; eng.
   PubMed Web of Science ®Google Scholar
• Nalliah CJ, Sanders P, Kalman JM. Obstructive sleep apnea treatment and atrial fibrillation: a need for definitive evidence. J Cardiovasc Electrophysiol. 2016 Aug;27(8):1001–1010. PubMed PMID: 27060686; eng.
   PubMed Web of Science ®Google Scholar
• Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23;62(4):300–305. PubMed PMID: 23623910; eng.
   PubMed Web of Science ®Google Scholar
• Holmqvist F, Guan N, Zhu Z, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Am Heart J. 2015 May;169(5):647–654.e2. PubMed PMID: 25965712; eng.
   PubMed Web of Science ®Google Scholar
• Piccini JP, Sinner MF, Greiner MA, et al. Outcomes of medicare beneficiaries undergoing catheter ablation for atrial fibrillation. CIRCULATIONAHA.112.109330]. Circulation. 2012;126(18):2200.
   PubMed Web of Science ®Google Scholar
• Deshmukh A, Patel NJ, Pant S, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013 Nov 5;128(19):2104–2112. PubMed PMID: 24061087.
   PubMed Web of Science ®Google Scholar
• Hoyt H, Bhonsale A, Chilukuri K, et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 2011 Dec 1;8(12):1869–1874.
   PubMed Web of Science ®Google Scholar
• Cappato R, Calkins H, Chen S-A, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32.
   PubMed Web of Science ®Google Scholar
• Tanaka-Esposito CC, Chung MK, Abraham JM, et al. Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin. J Interv Card Electrophysiol. 2013 Aug 1;37(2):163–168.
   PubMed Web of Science ®Google Scholar
• Okada M, Inoue K, Tanaka K, et al. Efficacy and safety of figure-of-eight suture for hemostasis after radiofrequency catheter ablation for atrial fibrillation. Circ Journal: Official Journal Jpn Circ Soc. 2018 Mar 23;82(4):956–964. PubMed PMID: 29375108; eng.
   PubMed Web of Science ®Google Scholar
• Dagres N, Hindricks G, Kottkamp H, et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol. 2009;20(9):1014–1019.
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Asirvatham SJ, Friedman PA, et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol. 2005;16(11):1172–1179.
   PubMed Web of Science ®Google Scholar
• Pollack CV, Reilly PA, Eikelboom J, et al. Idarucizumab for dabigatran reversal. New England J Med. 2015 Aug 6;373(6):511–520.
   PubMed Web of Science ®Google Scholar
• Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet Alfa for the reversal of factor Xa inhibitor activity. New England J Med. 2015 Dec 17;373(25):2413–2424.
   PubMed Web of Science ®Google Scholar
• Michowitz Y, Rahkovich M, Oral H, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(2):274.
   PubMed Web of Science ®Google Scholar
• Cappato R, Calkins H, Chen S-A, et al. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol. 2011 Dec 13;58(25):2696–2697.
   PubMed Web of Science ®Google Scholar
• Herrera Siklódy C, Deneke T, Hocini M, et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011 Aug 9;58(7):681–688.
   PubMed Web of Science ®Google Scholar
• Lickfett L, Hackenbroch M, Lewalter T, et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol. 2006;17(1):1–7.
   PubMed Web of Science ®Google Scholar
• Sugrue A, Siontis KC, Piccini JP, et al. Periprocedural anticoagulation management for atrial fibrillation ablation: current knowledge and future directions. Curr Treat Options Cardiovasc Med. 2018 Jan 25;20(1):3.
   PubMedGoogle Scholar
• Ho SY, Cabrera JA, Sanchez-Quintana D. Left atrial anatomy revisited. Circ Arrhythm Electrophysiol. 2012;5(1):220.
   PubMed Web of Science ®Google Scholar
• Chavez P, Messerli FH, Casso Dominguez A, et al. Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports. Open Heart. 2015;2:1.
   Google Scholar
• Miyazaki S, Taniguchi H, Kusa S, et al. Factors associated with periesophageal vagal nerve injury after pulmonary vein antrum isolation. J Am Heart Association. 2014;3:5.
   Web of Science ®Google Scholar
• Saad EB, Rossillo A, Saad CP, et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation. Circulation. 2003;108(25):3102.
   PubMed Web of Science ®Google Scholar
• Dong JUN, Vasamreddy CR, Jayam V, et al. Incidence and predictors of pulmonary vein stenosis following catheter ablation of atrial fibrillation using the anatomic pulmonary vein ablation approach: results from paired magnetic resonance imaging. J Cardiovasc Electrophysiol. 2005;16(8):845–852.
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation. Circulation. 2003;107(21):2710.
   PubMed Web of Science ®Google Scholar
• Tamborero D, Mont L, Nava S, et al. Incidence of pulmonary vein stenosis in patients submitted to atrial fibrillation ablation: a comparison of the selective segmental ostial ablation vs the circumferential pulmonary veins ablation. J Interv Card Electrophysiol. 2005 Oct 01;14(1):21–25.
   PubMed Web of Science ®Google Scholar
• Qureshi AM, Prieto LR, Latson LA, et al. Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation. Circulation. 2003;108(11):1336.
   PubMed Web of Science ®Google Scholar
• De Potter TJR, Schmidt B, Chun KRJ, et al. Drug-eluting stents for the treatment of pulmonary vein stenosis after atrial fibrillation ablation. EP Europace. 2011;13(1):57–61.
   PubMed Web of Science ®Google Scholar
• Fender EA, Widmer RJ, Hodge DO, et al. Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: presentation, management and clinical outcomes. Circulation. 2016. DOI:10.1161/CIRCULATIONAHA.116.021949
   Google Scholar
• Arentz T, Jander N, Von Rosenthal J, et al. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J. 2003;24(10):963–969.
   PubMed Web of Science ®Google Scholar
• Okumura Y, Henz BD, Bunch TJ, et al. Distortion of right superior pulmonary vein anatomy by balloon catheters as a contributor to phrenic nerve injury. J Cardiovasc Electrophysiol. 2009;20(10):1151–1157.
   PubMed Web of Science ®Google Scholar
• Yong JS, Dewire J, Barcelon B, et al. Phrenic nerve injury: an underrecognized and potentially preventable complication of pulmonary vein isolation using a wide-area circumferential ablation approach. J Cardiovasc Electrophysiol. 2013;24(10):1086–1091.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Chun KRJ, Ouyang F, et al. Three-dimensional reconstruction of the anatomic course of the right phrenic nerve in humans by pace mapping. Heart Rhythm. 2009;5(8):1120–1126.
   Web of Science ®Google Scholar
• Squara F, Desjardins B, Marchlinski FE, et al. Prospective 3-dimensional computed tomography segmentation of the pericardiac right phrenic nerve in the setting of atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2014 Jun;7(3):561–562. PubMed PMID: 24951576; eng.
   PubMed Web of Science ®Google Scholar
• Arruda M, Mlcochova H, Prasad SK, et al. Electrical isolation of the superior vena cava: an adjunctive strategy to pulmonary vein antrum isolation improving the outcome of AF ablation. J Cardiovasc Electrophysiol. 2007;18(12):1261–1266.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Usui E, Kusa S, et al. Prevalence and clinical outcome of phrenic nerve injury during superior vena cava isolation and circumferential pulmonary vein antrum isolation using radiofrequency energy. Am Heart J. 2014 Dec 1;168(6):846–853.
   PubMed Web of Science ®Google Scholar
• Zeljko HM, Mont L, Sitges M, et al. Entrapment of the circular mapping catheter in the mitral valve in two patients undergoing atrial fibrillation ablation. EP Europace. 2011;13(1):132–133.
   PubMed Web of Science ®Google Scholar
• Gibson DN, Di Biase L, Mohanty P, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm. 2011 Sep 1;8(9):1364–1371.
   PubMed Web of Science ®Google Scholar
• Witt C, Powell B, Holmes D, et al. Recurrent dyspnea following multiple ablations for atrial fibrillation explained by the “stiff left atrial syndrome”. Catheter Cardiovasc Interv. 2013;82(5):E747–E749.
   PubMed Web of Science ®Google Scholar
• Bertaglia E, Stabile G, Pappone A, et al. Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(10):1069–1074.
   PubMed Web of Science ®Google Scholar
• Chugh A, Makkar A, Yen Ho S, et al. Manifestations of coronary arterial injury during catheter ablation of atrial fibrillation and related arrhythmias. Heart Rhythm. 2013 Nov 1;10(11):1638–1645.
   PubMed Web of Science ®Google Scholar
• Wong KCK, Lim C, Sadarmin PP, et al. High incidence of acute sub-clinical circumflex artery ‘injury’ following mitral isthmus ablation. Eur Heart J. 2011;32(15):1881–1890.
   PubMed Web of Science ®Google Scholar
• Barra S, Gopalan D, Baran J, et al. Acute and sub-acute sinus node dysfunction following pulmonary vein isolation: a case series. Eur Heart J Case Rep. 2018;ytx020. DOI:10.1093/ehjcr/ytx020
   Google Scholar
• Pardo Meo J, Scanavacca M, Sosa E, et al. Atrial coronary arteries in areas involved in atrial fibrillation catheter ablation. Circ Arrhythm Electrophysiol. 2010 Dec;3(6):600–605. PubMed PMID: 20852298; eng.
   PubMed Web of Science ®Google Scholar
• Cappato R, Calkins H, Chen S-A, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100.
   PubMed Web of Science ®Google Scholar
• Pallisgaard JL, Gislason GH, Hansen J, et al. Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study. Eur Heart J. 2018;39(6):442–449.
   PubMed Web of Science ®Google Scholar
• Riahi S, Arbelo E, Brugada J, et al. Regional differences in referral, procedures, and outcome after ablation for atrial fibrillation in Europe: a report from the atrial fibrillation ablation pilot registry of the European society of cardiology. Europace. 2016 Feb;18(2):191–200. PubMed PMID: 26647447; eng.
   PubMed Web of Science ®Google Scholar
• Amit GNJ, Morillo CA, Casas JP, et al. Efficacy and safety of ablation for patients with nonparoxysmal atrial fibrillation. Cochrane Database Syst Rev. 2016;8:CD012088.
   Google Scholar
• Wynn GJ, Das M, Bonnett LJ, et al. Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials. Circ Arrhythm Electrophysiol. 2014 Oct;7(5):841–852. PubMed PMID: 25132078; eng.
   PubMed Web of Science ®Google Scholar
• Nielsen JC, Johannessen A, Raatikainen P, et al. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial. Heart. 2017 Mar;103(5):368–376. PubMed PMID: 27566295; eng.
   PubMed Web of Science ®Google Scholar
• Packer DL Presented by Dr. Douglas L. Packer at the Heart Rhythm Society Scientific Session, May 10, 2018, Boston, MA.
   Google Scholar
• Lee G, Sparks PB, Morton JB, et al. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol. 2011 Feb;22(2):163–168. PubMed PMID: 20731742; eng.
   PubMed Web of Science ®Google Scholar
• Rostock T, Salukhe TV, Steven D, et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation. Heart Rhythm. 2011 Sep;8(9):1391–1397. PubMed PMID: 21699825; eng.
   PubMed Web of Science ®Google Scholar
• Winkle RA, Jarman JW, Mead RH, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score. Heart Rhythm. 2016 Nov;13(11):2119–2125. PubMed PMID: 27435586; eng.
   PubMed Web of Science ®Google Scholar
• Kosiuk J, Dinov B, Kornej J, et al. Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score. Heart Rhythm. 2015 Nov;12(11):2207–2212. PubMed PMID: 26144350; eng.
   PubMed Web of Science ®Google Scholar
• Schreiber D, Rostock T, Frohlich M, et al. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success. Circ Arrhythm Electrophysiol. 2015 Apr;8(2):308–317. PubMed PMID: 25744570; eng.
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014 Feb 5;311(5):498–506. PubMed PMID: 24496537.
   PubMed Web of Science ®Google Scholar
• Mahnkopf C, Badger TJ, Burgon NS, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010 Oct;7(10):1475–1481. PubMed PMID: 20601148; PubMed Central PMCID: PMCPMC3106345. eng.
   PubMed Web of Science ®Google Scholar
• Vlachos K, Efremidis M, Letsas KP, et al. Low-voltage areas detected by high-density electroanatomical mapping predict recurrence after ablation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2017 Dec;28(12):1393–1402. PubMed PMID: 28884923; eng.
   PubMed Web of Science ®Google Scholar
• Khurram IM, Maqbool F, Berger RD, et al. Association between left atrial stiffness index and atrial fibrillation recurrence in patients undergoing left atrial ablation. Circ Arrhythm Electrophysiol. 2016;9(3). DOI:10.1161/CIRCEP.115.003163
   Web of Science ®Google Scholar
• Andrade JG, Khairy P, Verma A, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012 Jan;35(1):106–116. PubMed PMID: 22054110; eng.
   PubMed Web of Science ®Google Scholar
• Andrade JG, Khairy P, Macle L, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation. Circ Arrhythm Electrophysiol. 2014;7(1):69.
   PubMed Web of Science ®Google Scholar
• Gaztanaga L, Frankel DS, Kohari M, et al. Time to recurrence of atrial fibrillation influences outcome following catheter ablation. Heart Rhythm. 2013 Jan;10(1):2–9. PubMed PMID: 22982966.
   PubMed Web of Science ®Google Scholar
• Chao T-F, Cheng -C-C, Lin W-S, et al. Associations among the CHADS2 score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2012;8(8):1155–1159.
   Web of Science ®Google Scholar
• Piorkowski C, Eitel C, Rolf S, et al. Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol. 2011 Apr;4(2):157–165. PubMed PMID: 21248246; eng.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Kautzner J, Natale A, et al. Locations of high contact force during left atrial mapping in atrial fibrillation patients: electrogram amplitude and impedance are poor predictors of electrode-tissue contact force for ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2013 Aug;6(4):746–753. PubMed PMID: 23873143; eng.
   PubMed Web of Science ®Google Scholar
• Natale A, Reddy VY, Monir G, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014 Aug 19;64(7):647–656. PubMed PMID: 25125294.
   PubMed Web of Science ®Google Scholar
• Goode JS Jr., Taylor RL, Buffington CW, et al. High-frequency jet ventilation: utility in posterior left atrial catheter ablation. Heart Rhythm. 2006 Jan;3(1):13–19. PubMed PMID: 16399046; eng.
   PubMed Web of Science ®Google Scholar
• Kumar S, Morton JB, Halloran K, et al. Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm. 2012 Jul;9(7):1041–1047.e1. PubMed PMID: 22342855; eng.
   PubMed Web of Science ®Google Scholar
• Hutchinson MD, Garcia FC, Mandel JE, et al. Efforts to enhance catheter stability improve atrial fibrillation ablation outcome. Heart Rhythm. 2013 Mar;10(3):347–353. PubMed PMID: 23128019.
   PubMed Web of Science ®Google Scholar
• Leong-Sit P, Roux JF, Zado E, et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm Electrophysiol. 2011 Feb;4(1):11–14. PubMed PMID: 21076158; eng.
   PubMed Web of Science ®Google Scholar
• Kaitani K, The E-AFTI, Inoue K, et al. Efficacy of antiarrhythmic drugs short-term use after catheter ablation for atrial fibrillation (EAST-AF) trial. Eur Heart J. 2016;37(7):610–618.
   PubMed Web of Science ®Google Scholar
• Haissaguerre M, Sanders P, Hocini M, et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol. 2005 Nov;16(11):1125–1137. PubMed PMID: 16302892; eng.
   PubMed Web of Science ®Google Scholar
• Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015 May 7;372(19):1812–1822. PubMed PMID: 25946280.
   PubMed Web of Science ®Google Scholar
• Narayan SM, Shivkumar K, Krummen DE, et al. Panoramic electrophysiological mapping but not electrogram morphology identifies stable sources for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6(1):58.
   PubMed Web of Science ®Google Scholar
• Choi EK, Zhao Y, Everett T, et al. Ganglionated plexi as neuromodulation targets for atrial fibrillation. J Cardiovasc Electrophysiol. 2017 Dec;28(12):1485–1491. PubMed PMID: 28833764; PubMed Central PMCID: PMCPMC5722676. eng.
   PubMed Web of Science ®Google Scholar